Search Results - "Ramos, Maritza"

A Novel Combination of Sotorasib and Metformin Enhances Cytotoxicity and Apoptosis in KRAS-Mutated Non-Small Cell Lung Cancer Cell Lines through MAPK and P70S6K Inhibition by Barrios-Bernal, Pedro, Lucio-Lozada, José, Ramos-Ramírez, Maritza, Hernández-Pedro, Norma, Arrieta, Oscar

“…Novel inhibitors of KRAS with G12C mutation (sotorasib) have demonstrated short-lasting responses due to resistance mediated by the AKT-mTOR-P70S6K pathway. In…”
Get full text

STK11 and KEAP1 mutations in non-small cell lung cancer patients: Descriptive analysis and prognostic value among Hispanics (STRIKE registry-CLICaP) by Cordeiro de Lima, Vladmir C., Corassa, Marcelo, Saldanha, Erick, Freitas, Helano, Arrieta, Oscar, Raez, Luis, Samtani, Suraj, Ramos, Maritza, Rojas, Carlos, Burotto, Mauricio, Chamorro, Diego F., Recondo, Gonzalo, Ruiz-Patiño, Alejandro, Más, Luis, Zatarain-Barrón, Lucia, Mejía, Sergio, Nicolas Minata, José, Martín, Claudio, Bautista Blaquier, Juan, Motta Guerrero, Rodrigo, Aliaga-Macha, Carlos, Carracedo, Carlos, Ordóñez- Reyes, Camila, Garcia-Robledo, Juan Esteban, Corrales, Luis, Sotelo, Carolina, Ricaurte, Luisa, Santoyo, Nicolas, Cuello, Mauricio, Jaller, Elvira, Rodríguez, July, Archila, Pilar, Bermudez, Maritza, Gamez, Tatiana, Russo, Alessandro, Viola, Lucia, Malapelle, Umberto, de Miguel Perez, Diego, Rolfo, Christian, Rosell, Rafael, Cardona, Andrés F.

“…•STK11 and KEAP1 have been described as poor prognostic factors in patients treated with immune checkpoint inhibitors (ICIs).•This is the larger study to…”
Get full text

Risk of Developing Checkpoint Immune Pneumonitis and Its Effect on Overall Survival in Non-small Cell Lung Cancer Patients Previously Treated With Radiotherapy by Barrón, Feliciano, Sánchez, Roberto, Arroyo-Hernández, Marisol, Blanco, Carolina, Zatarain-Barrón, Zyanya L, Catalán, Rodrigo, Ramos-Ramírez, Maritza, Cardona, Andrés F, Flores-Estrada, Diana, Arrieta, Oscar

“…Immune checkpoint inhibitor-related pneumonitis (ICIP) is a potentially life threatening immune-related adverse event (irAE), especially in non-small cell lung…”
Get full text

Cost-effectiveness analysis of first and second-generation EGFR tyrosine kinase inhibitors as first line of treatment for patients with NSCLC harboring EGFR mutations by Arrieta, Oscar, Catalán, Rodrigo, Guzmán-Vazquez, Silvia, Barrón, Feliciano, Lara-Mejía, Luis, Soto-Molina, Herman, Ramos-Ramírez, Maritza, Flores-Estrada, Diana, de la Garza, Jaime

“…Tyrosine-kinase inhibitors (TKIs) have become the cornerstone treatment of patients with non-small cell lung cancer that harbor oncogenic EGFR mutations. The…”
Get full text

Clinical Impact of the COVID‐19 Pandemic in Mexican Patients with Thoracic Malignancies by Arrieta, Oscar, Lara‐Mejía, Luis, Bautista‐GonzÁlez, Elysse, Heredia, David, Turcott, Jenny G., BarrÓn, Feliciano, Ramos‐Ramírez, Maritza, Cabrera‐Miranda, Luis, Salinas Padilla, Miguel Ángel, Aguerrebere, Mercedes, Cardona, Andrés F., Rolfo, Christian, Arroyo‐HernÁndez, Marisol, Soto‐Pérez‐de‐Celis, Enrique, Baéz‐Saldaña, Renata

“…Background Accumulated evidence indicates that patients with lung cancer are a vulnerable population throughout the pandemic. Limited information is available…”
Get full text

LKB1 Loss Assessed by Immunohistochemistry as a Prognostic Marker to First-Line Therapy in Advanced Non-Small-Cell Lung Cancer by Avilés-Salas, Alejandro, Díaz-García, Diego A, Lara-Mejía, Luis, Cardona, Andrés F, Orozco-Morales, Mario, Catalán, Rodrigo, Hernández-Pedro, Norma Y, Rios-Garcia, Eduardo, Ramos-Ramírez, Maritza, Arrieta, Oscar

“…(1) Background: Liver kinase B1 (LKB1) is a tumor suppressor gene involved in cell growth and metabolism. However, its alterations are not routinely assessed…”
Get full text

Efficacy, Safety, and Cost-Minimization Analysis of Continuous Infusion of Low-Dose Gemcitabine Plus Cisplatin in Patients With Unresectable Malignant Pleural Mesothelioma by Arrieta, Oscar, Muñoz-Montaño, Wendy, Muñiz-Hernández, Sae, Campos, Saul, Catalán, Rodrigo, Soto-Molina, Herman, Guzmán Vázquez, Silvia, Díaz-Álvarez, Osvaldo, Martínez-Pacheco, Victor, Turcott, Jenny G, Ramos-Ramírez, Maritza, Cabrera-Miranda, Luis, Barrón, Feliciano, Cardona, Andrés F

“…Malignant pleural mesothelioma (MPM) is rare and aggressive neoplasia, with a poor prognosis; furthermore, the monetary cost of its treatment represents a…”
Get full text

Re‐irradiation in patients with progressive or recurrent brain metastases from extracranial solid tumors: A novel prognostic index by Gutierrez Torres, Salvador, Maldonado Magos, Federico, Turcott, Jenny G., Hernandez‐Martinez, Juan‐Manuel, Cacho‐Díaz, Bernardo, Cardona, Andrés F., Mota‐García, Aida, Lozano Ruiz, Francisco, Ramos‐Ramirez, Maritza, Arrieta, Oscar

“…Background Most studies evaluating factors associated with the survival of patients with brain metastases (BM) have focused on patients with newly diagnosed…”
Get full text

Evaluation of a risk-sharing agreement for atezolizumab treatment in patients with non-small cell lung cancer: a strategy to improve access in low-income countries by Arrieta, Oscar, Ramos-Ramírez, Maritza, Garcés-Flores, Homero, Cabrera-Miranda, Luis A, Gómez-García, Ana Pamela, Soto-Molina, Herman, Cardona, Andrés F, Valencia-Velarde, Ángel, Gálvez-Niño, Marco, Guzmán-Vázquez, Silvia

“…Using immune checkpoint inhibitors (IO) is a promising approach to maximize clinical benefits for patients with non-small cell lung cancer (NSCLC). PD-L1…”
Get full text

Early Incorporation to Palliative Care (EPC) in Patients With Advanced Non-Small Cell Lung Cancer: The PACO Randomized Clinical Trial by Allende, Silvia, Turcott, Jenny G, Verástegui, Emma, Rodríguez-Mayoral, Oscar, Flores-Estrada, Diana, Pérez Camargo, Dana Aline, Ramos-Ramírez, Maritza, Martínez-Hernández, Jorge-Negueb, Oñate-Ocaña, Luis F, Pina, Pamela Soberanis, Cardona, Andrés F, Arrieta, Oscar

“…Patients with non-small cell lung cancer (NSCLC) experience a considerable disease burden, evident in symptomatic and psychological spheres. Advanced cancer…”
Get full text

A high number of co-occurring genomic alterations detected by NGS is associated with worse clinical outcomes in advanced EGFR-mutant lung adenocarcinoma: Data from LATAM population by Heredia, David, Mas, Luis, Cardona, Andres F., Oyervides, Víctor, Motta Guerrero, Rodrigo, Galvez-Nino, Marco, Lara-Mejía, Luis, Aliaga-Macha, Carlos, Carracedo, Carlos, Varela-Santoyo, Edgar, Ramos-Ramírez, Maritza, Davila-Dupont, David, Martínez, Juan, Cruz-Rico, Graciela, Remon, Jordi, Arrieta, Oscar

“…•Co-occurring genomic alterations at diagnosis might represent de novo and primary resistance mechanisms to tyrosine kinase inhibitors (TKIs) in advanced…”
Get full text

Impact of KRASG12D subtype and concurrent pathogenic mutations on advanced non-small cell lung cancer outcomes by Caballé-Perez, Enrique, Hernández-Pedro, Norma, Ramos-Ramírez, Maritza, Barrios-Bernal, Pedro, Romero-Núñez, Eunice, Lucio-Lozada, José, Ávila-Ríos, Santiago, Reyes-Terán, Gustavo, Cardona, Andrés F., Arrieta, Oscar

“…Purpose Mutations in the Kirsten rat sarcoma viral (KRAS) oncogene constitute a significant driver of lung adenocarcinoma, present in 10–40% of patients, which…”
Get full text

The Evolution of Clinically Aggressive Triple-Negative Breast Cancer Shows a Large Mutational Diversity and Early Metastasis to Lymph Nodes by Martínez-Gregorio, Héctor, Rojas-Jiménez, Ernesto, Mejía-Gómez, Javier César, Díaz-Velásquez, Clara, Quezada-Urban, Rosalía, Vallejo-Lecuona, Fernando, de la Cruz-Montoya, Aldo, Porras-Reyes, Fany Iris, Pérez-Sánchez, Víctor Manuel, Maldonado-Martínez, Héctor Aquiles, Robles-Estrada, Maybelline, Bargalló-Rocha, Enrique, Cabrera-Galeana, Paula, Ramos-Ramírez, Maritza, Chirino, Yolanda Irasema, Alonso Herrera, Luis, Terrazas, Luis Ignacio, Frecha, Cecilia, Oliver, Javier, Perdomo, Sandra, Vaca-Paniagua, Felipe

“…In triple-negative breast cancer (TNBC), only 30% of patients treated with neoadjuvant chemotherapy achieve a pathological complete response after treatment…”
Get full text

Comprehensive Genomic Profile of Heterogeneous Long Follow-Up Triple-Negative Breast Cancer and Its Clinical Characteristics Shows DNA Repair Deficiency Has Better Prognostic by Rojas-Jiménez, Ernesto, Mejía-Gómez, Javier César, Díaz-Velásquez, Clara, Quezada-Urban, Rosalía, Martínez Gregorio, Héctor, Vallejo-Lecuona, Fernando, de la Cruz-Montoya, Aldo, Porras Reyes, Fany Iris, Pérez-Sánchez, Víctor Manuel, Maldonado-Martínez, Héctor Aquiles, Robles-Estrada, Maybelline, Bargalló-Rocha, Enrique, Cabrera-Galeana, Paula, Ramos-Ramírez, Maritza, Chirino, Yolanda Irasema, Alonso Herrera, Luis, Terrazas, Luis Ignacio, Oliver, Javier, Frecha, Cecilia, Perdomo, Sandra, Vaca-Paniagua, Felipe

“…Triple-negative breast cancer (TNBC) presents a marked diversity at the molecular level, which promotes a clinical heterogeneity that further complicates…”
Get full text

Impacto de la eficiencia en la gestión de la política educativa en salud integral de Lima Metropolitana by Toribio Ramos, Maritza

“…Las políticas públicas en educación básica regular (PP EBR) se investigaron desde diferentes contextos que se evidenciaron durante el proceso de revisión desde…”
Get full text

A phase II study of alectinib in combination with bevacizumab as first-line treatment in advanced NSCLC with confirmed ALK fusion: ALEK-B trial by Arrieta, Oscar Gerardo, Lara Mejía, Luis Antonio, Cabrera, Luis Antonio, Ramos, Maritza, Heredia, David Jose, Cruz-Rico, Graciela, Salinas, Miguel Angel, Cardenas Fernández, Daniela, Zatarain-Barron, Zyanya Lucía, Cardona Zorrilla, Andres Felipe, Remon Masip, Jordi, Rosell, Rafael

“…9074 Background: Alectinib is one of the standard treatment options as an upfront therapy in advanced ALK-rearranged non-small-cell lung cancer. However, all…”
Get full text

Porno, pornógrafos, monstruos. Una aproximación pospornográfica al cuerpo bogotano by Mónica Maritza Ramos González

“…El objetivo de este artículo es establecer, de la mano de Michel Foucault, Paul B. Preciado y Hilderman Cardona, entre otros autores, un mapa que exhiba…”
Get full text

Nitroglycerin (NTG) plus whole intracranial radiotherapy for brain metastases (BM) in non-small cell cancer patient (NSCLC): A randomized open label, phase II clinical trial by Arrieta Rodriguez, Oscar Gerardo, Hernández-Pedro, Norma, Maldonado, Federico, Ramos, Maritza, Yamamoto-Ramos, Masao, López, Diego, Lozano, Francisco, Zatarain-Barron, Zyanya Lucía, Cruz-Rico, Graciela, Barrios-Bernal, Pedro, Orozco-Morales, Mario, Cacho, Bernardo, Flores-Estrada, Diana, Cardona Zorrilla, Andres Felipe, Rolfo, Christian Diego

“…Abstract only 9114 Background: Hypoxia has been associated with chemo-radioresistance secondary to Vascular Endothelial Growth Factor Receptor induced by…”
Get full text

Recommendations for detection, prioritization, and treatment of thoracic oncology patients during the COVID‐19 pandemic: the THOCOoP cooperative group by Arrieta, Oscar, Cardona, Andrés F., Lara-Mejía, Luis, Heredia, David, Barrón, Feliciano, Zatarain-Barrón, Zyanya Lucia, Lozano, Francisco, de Lima, Vladmir Cordeiro, Maldonado, Federico, Corona-Cruz, Francisco, Ramos, Maritza, Cabrera, Luis, Martin, Claudio, Corrales, Luis, Cuello, Mauricio, Arroyo-Hernández, Marisol, Aman, Enrique, Bacon, Ludwing, Baez, Renata, Benitez, Sergio, Botero, Antonio, Burotto, Mauricio, Caglevic, Christian, Ferraris, Gustavo, Freitas, Helano, Kaen, Diego Lucas, Lamot, Sebastián, Lyons, Gustavo, Mas, Luis, Mata, Andrea, Mathias, Clarissa, Muñoz, Alvaro, Patane, Ana Karina, Oblitas, George, Pino, Luis, Raez, Luis E., Remon, Jordi, Rojas, Leonardo, Rolfo, Christian, Ruiz-Patiño, Alejandro, Samtani, Suraj, Viola, Lucia, Viteri, Santiago, Rosell, Rafael

“…The world currently faces a pandemic due to SARS-CoV-2. Relevant information has emerged regarding the higher risk of poor outcomes in lung cancer patients. As…”
Get full text

Telework Decision Strategy: A Systematic Review by Lopez, Maritza Ramos

“…The U.S. Government telework program has stagnated, with only 40 percent of the population considered telework eligible, a slight decline from 2012, and less…”
Get full text